Ocumension Therapeutics (HK:1477) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Ocumension Therapeutics has announced a further delay in the dispatch of a crucial circular to its shareholders, which was originally scheduled for September 16, 2024, and is now expected around September 23, 2024. The circular is to include details on significant acquisition activities, in-licensing of products, and proposals for issuing consideration shares, as well as information on connected transactions involving purchase arrangements and royalty and milestone payments.
For further insights into HK:1477 stock, check out TipRanks’ Stock Analysis page.